表紙
市場調查報告書

針對醫療的奈米技術:題目研究

Nanotechnology in Medicine - Thematic Research

出版商 GlobalData 商品編碼 919460
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
針對醫療的奈米技術:題目研究 Nanotechnology in Medicine - Thematic Research
出版日期: 2019年08月30日內容資訊: 英文 27 Pages
簡介

面向本報告提供醫療產業奈米技術 (奈米醫藥)的活用狀況相關分析,彙整針對醫療的奈米技術概要和主要用途 (顯影劑,治療藥等),全球醫療產業的背景情況 (各種疾病的發病者數,臨床實驗趨勢及其他),各市場區隔詳細趨勢 (微脂體,微泡沫等),主要企業的企業發展趨勢,市場規模趨勢預測等資訊,為您概述為以下內容。

目錄

  • 市場趨勢
    • 科學技術趨勢
    • 宏觀經濟趨勢
    • 法規趨勢
  • 產業分析
    • 市場區隔
    • 微脂體
    • 微泡沫
    • 案例研究
    • 企業合併·收購 (M&A)
    • 年表
    • 臨床實驗趨勢
  • 價值鏈
  • 企業
    • 上市公司
    • 非上市公司
  • 附錄:關於「Thematic Research」的分析方法
目錄
Product Code: GDHC-TR-S008

Nanomedicine refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the ability to target specific cells or tissues. These materials are produced on a nanoscale level and are safe to introduce into the body. Applications for nanotechnology in medicine include imaging, diagnosis, or the delivery of drugs that will help medical professionals treat various diseases. In addition to targeted delivery of therapeutics, nanotechnology can also be used to release drugs in a controlled manner. This can result in improved outcomes for patients due to a reduction in toxicity, more efficient delivery of therapeutic molecules, and longer lifetime of drugs within the body.

Key Highlights

  • Players in the nanomedicine market range from private companies that make small annual revenues to large companies that dominate multiple industries, generating large revenues from many patents and FDA-approved drugs.
  • Nanomedicines are a combination of nanotechnology with the drug itself, and are required to pass standard regulatory milestones. This includes proven safety and efficacy based on pre-clinical and clinical trials.
  • Nanotechnologies are used as imagine contrast agents (microbubbles), for diagnostic purposes (liposomes and nanoparticles) and therapy (liposomes, nanoparticles and therapeutic microbubbles in development).

Scope

  • This thematic report provides an overview of the use of nanotechnology in the medical device field.
  • The key trends within this theme include understanding different patient populations and target specification.
  • Our unique thematic analysis dives deep into the major sub-segments of nanotechnology in medicine, including liposomes, microbubbles and nanoparticles, and the market outlook for each type of technology.
  • Companies that dominate the nanotechnology in medicine theme include Janssen, Gilead, GE Healthcare and Sanofi.

Reasons to buy

  • Understand the nanotechnology industry through accessing the impacts and observing case studies identifying the key leaders, those who are likely to disrupt and those who fell behind.
  • Assess the different types of nanoparticles, their current use in medicine and their future outlook.
  • GlobalData's thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.

Table of Contents

  • TRENDS
    • Technology/Scientific Trends
    • Macroeconomic Trends
    • Regulatory Trends
  • INDUSTRY ANALYSIS
    • Market Segmentation
    • Liposomes
    • Microbubbles
    • Generation of Revenue
    • Competitive Analysis
    • Case Studies
    • Mergers and Acquisitions
    • Timeline
    • Clinical Trials
  • VALUE CHAIN
    • COMPANIES
    • Public Companies
    • Private Companies
  • APPENDIX: OUR THEMATIC RESEARCH METHODOLOGY
Back to Top